date,title,source
Oct-17-18,Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock,GlobeNewswire
Oct-18-18,Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock,GlobeNewswire
Oct-22-18,"Krystal Biotech Inc (KRYS) President and CEO Krish S Krishnan Bought $500,000 of Shares",GuruFocus.com
Oct-22-18,Chardan Serves as Lead Manager for Krystal Biotech,PR Newswire
Oct-23-18,Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters Over-Allotment Option,GlobeNewswire
Nov-05-18,Krystal Biotech Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-20-18,Krystal Biotech to Present at Evercore ISI HealthCONx,GlobeNewswire
Nov-21-18,"New Research Coverage Highlights VSE, Weyco Group, Funko, B. Riley Financial, Krystal Biotech, and Xcel Brands  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-19-18,Krystal Biotech Completes Dosing in the GEM-Phase 2 Study in Pediatric Patients for the Treatment of Dystrophic Epidermolysis Bullosa,GlobeNewswire
Jan-15-19,Krystal Biotech Completes Construction of Ancoris - A New GMP Facility for Commercial Manufacturing of a Viral Vector-Based Gene Therapy to Treat Dystrophic Epidermolysis Bullosa,GlobeNewswire
Jan-18-19,"Danforth Advisors entering Pittsburgh, focusing on life sciences sector",American City Business Journals
Feb-22-19,Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Mar-01-19,Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-04-19,Krystal Strengthens Board of Directors with Appointment of Julian S. Gangolli,GlobeNewswire
